Semicarbazide derivatives as kinase inhibitors

Details for Australian Patent Application No. 2005217041 (hide)

Owner Merck Patent GmbH

Inventors Buchstaller, Hans-Peter; Zenke, Frank; Wiesner, Matthias; Grell, Matthias; Stieber, Frank; Amendt, Christiane; Sirrenberg, Christian; Finsinger, Dirk

Agent Davies Collison Cave

Pub. Number AU-A-2005217041

PCT Pub. Number WO2005/082853

Priority 04004330.9 26.02.04 EP

Filing date 14 February 2005

Wipo publication date 9 September 2005

International Classifications

C07D 213/68 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/81 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

19 October 2006 PCT application entered the National Phase

  PCT publication WO2005/082853 Priority application(s): WO2005/082853

1 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005217042-Benzimidazolyl derivatives as kinase inhibitors

2005217033-Isoquinoline derivatives